trending Market Intelligence /marketintelligence/en/news-insights/trending/iaw4z7jmjbi_zsgvzc7dkg2 content esgSubNav
In This List

Catalyst Pharmaceuticals names chief commercial officer

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Catalyst Pharmaceuticals names chief commercial officer

Catalyst Pharmaceuticals Inc. appointed Daniel Brennan as chief commercial officer.

Brennan will lead the biopharmaceutical company's marketing, sales and commercial operations. He most recently served as COO at Edge Therapeutics Inc.